Keywords: مرگ برنامهریزی لیگاند 1; irAE; immune related adverse event; ECOG PS; European cooperative oncology group performance status; n.s.; not significant; EGFR; epidermal growth factor receptor; ALK; anaplastic lymphoma kinase; PD-L1; programmed death-ligand 1; TKI; tyrosine-kinase inh
مقالات ISI مرگ برنامهریزی لیگاند 1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مرگ برنامهریزی لیگاند 1; ARG-1; arginase 1; CCL-; CC motif chemokine ligand-; CXCL-; CX-C motif chemokine ligand-; CAF; cancer associated fibroblast; CO; carbon monoxide; CVB3; coxsackievirus B3; COX-2; cyclooxygenase-2; DC; dendritic cell; EAU; experimental autoimmune uveitis; E
Keywords: مرگ برنامهریزی لیگاند 1; AT; adipose tissue; BM; bone marrow; CsA; cyclosporine A; COX-2; cyclooxygenase-2; DEX; dexamethasone; DMEM; Dulbeccós modified Eaglés medium; DMSO; dimethyl sulfoxide; ELISA; enzyme-linked immunosorbent assay; FasL; Fas ligand; HGF; hepatocyte growth f
Keywords: مرگ برنامهریزی لیگاند 1; 5-FU; 5-fluorouracil; AF; atrial fibrillation; ALK; anaplastic lymphoma kinase; APD; action potential duration; APL; acute promyelocytic leukemia; BCR-ABL; breakpoint cluster region-Abelson; BTK; Bruton tyrosine kinase; CD20; cluster of differentiation 20
Keywords: مرگ برنامهریزی لیگاند 1; AE; adverse event; ALK; anaplastic lymphoma kinase; aNSCLC; advanced non-small cell lung cancer; DRG; diagnosis-related group; EGFR; epidermal growth factor receptor; GLM; generalized linear model; HMO; health maintenance organization; HR; hazard ratio; I
Keywords: مرگ برنامهریزی لیگاند 1; Immune Checkpoint; Virtual Microdissection; Molecular Subgroups; Immune Regulation; CCL; chemokine (C-C motif) ligand; CTNNB1; catenin beta 1; CXCL; chemokine (C-X-C motif) ligand; FDR; false discovery rate; FF; fresh frozen; FFPE; formalin-fixed paraffin
Keywords: مرگ برنامهریزی لیگاند 1; Programmed death-ligand 1; Indoleamine-2,3-dioxygenase; Siglec-9; Major histocompatibility complex; Tumor escape;
Keywords: مرگ برنامهریزی لیگاند 1; APCs; antigen presenting cells; ATP; adenosine triphosphate; BBB; blood brain barrier; BM; bone marrow; CB; cord blood; CNS; central nervous system; CSF; cerebrospinal fluid; DAMPs; danger associated molecular pattern molecules; DCs; dendritic cells; EAE;
Keywords: مرگ برنامهریزی لیگاند 1; PMNs; polymorphonuclear leukocytes; TANs; Tumor associated neutrophils; N1; proinflammatory; N2; anti-inflammatory tumor-promoting neutrophils; ELA2; neutrophil elastase; MMP8; neutrophils collagenase; MMP9; neutrophils gelatinase B; ECM; extracellular ma
Keywords: مرگ برنامهریزی لیگاند 1; DC; dendritic cell; ER; endoplasmic reticulum; IDO; indoleamine 2,3-dioxygenase; IFN-γ; interferon gamma; iNOS; inducible nitric oxide synthase; IRE1α; inositol-requiring enzyme 1 alpha; MAPK; mitogen-activated protein kinase; PD1; programmed death 1; P
Keywords: مرگ برنامهریزی لیگاند 1; Ab; antibody; ACT; adoptive cell therapy; ANG; angiopoietin; ATP; adenosine triphosphate; BMDC; bone marrow derived cell; CA4P; combretastatin A phosphate; CAF; cancer-associated fibroblast; CCL2; C-C motif ligand 2; CD; cluster differentiation antigen; C
Keywords: مرگ برنامهریزی لیگاند 1; Inflammation; Tumor; Cancer; Chemokines; Cytokines; Exosomes; G-CSF; granulocyte colony-stimulating factor; HIF-1; hypoxia-inducible factor 1; IGF2; insulin-like growth factor 2; IL; interleukin; MCP-1; monocyte chemoattractant protein-1; MDSC; myeloid-de
Keywords: مرگ برنامهریزی لیگاند 1; Immunological; Dysfunction; Sepsis; Antigen presentation; T/B lymphocytes; Tregs; PD-1; Immunoglobulins; Neutrophils; Complement; CNC; circulating neutrophil count; G-CSF; granulocyte-colony stimulating factor; GM-CSF; granulocyte-macrophage colony stimul
Keywords: مرگ برنامهریزی لیگاند 1; Ab; Antibody; ABC; ATP-binding cassette; AIOM; Associazione Italiana di Oncologia Medica; ALCAM; Activated leukocyte cell adhesion molecule; APOD; Apolipoprotein D; AR; androgen receptor; AURKA; Aurora kinase A; AURKB; Aurora kinase B; BCS; Biopharmaceuti
Keywords: مرگ برنامهریزی لیگاند 1; Gy; gray; Ab; antibody; TGF-β; transforming growth factor-β; TNF; tumor necrosis factor; SASP; senescence-associated secretory phenotype; MCP-1; monocyte chemoattractant protein-1; MHC; major histocompatibility complex; DAMP; damage-associated molecular
Keywords: مرگ برنامهریزی لیگاند 1; Breast cancer; Immune system; Biomarkers; Immunotherapies; Immune checkpoint blockade; Tumor vaccines; ADCC; antibody dependent cellular cytotoxicity; BiTES; bispecific single chain monoclonal antibodies; CAR; T cells engineered to express artificial chim
Emerging microRNAs in cancer diagnosis, progression, and immune surveillance
Keywords: مرگ برنامهریزی لیگاند 1; Cancer immunity; miR-21; miR-375; oncomiR; Prognostic biomarker; RAS pathway; AKT; serine/threonine-protein kinase; CIP2A; cancerous inhibitor of PP2A; ERK; extracellular-signal-regulated kinase; FFPE; formalin-fixed, paraffin-embedded; HNC; head and neck
Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers
Keywords: مرگ برنامهریزی لیگاند 1; Programmed death-ligand 1; C-reactive protein; Non-small cell lung cancer;
Significance of PD-L1 expression in pulmonary metastases from head and neck squamous cell carcinoma
Keywords: مرگ برنامهریزی لیگاند 1; Head and neck squamous cell carcinoma; Pulmonary metastasis; Pulmonary metastasectomy; Programmed death-ligand 1; Survival; Biomarker;
The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis
Keywords: مرگ برنامهریزی لیگاند 1; Head and neck cancer; Squamous cell carcinoma; Programmed death-ligand 1; PD-L1; HPV; Tumor-infiltrating lymphocytes; TIL; Survival; Meta-analysis;
Heterogeneity of PD-L1 Expression Among the Different Histological Components and Metastatic Lymph Nodes in Patients With Resected Lung Adenosquamous Carcinoma
Keywords: مرگ برنامهریزی لیگاند 1; Concordance rate; Histologic feature; Lymph node metastasis; Programmed death-ligand 1; Tumor-infiltrating lymphocyte;
Recent Developments in Oncology Immunotherapy, Implications for NPs Part 1
Keywords: مرگ برنامهریزی لیگاند 1; cytotoxic T-lymphocyte antigen 4; immune checkpoint inhibitor; immune-related adverse event; immunotherapy; nurse practitioner; programmed cell death 1; programmed death-ligand 1;
B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas
Keywords: مرگ برنامهریزی لیگاند 1; Bax; Bcl-2 associated X protein; Bcl-2; B-cell lymphoma-2; CCK-8; Cell counting kit-8; DMEM; Dulbecco's modified Eagle's medium; EMT; Epithelial-mesenchymal transition; FBS; Fetal bovine serum; GAPDH; Glyceraldehyde-3-phosphate dehydrogenase; GM-CSF; Gran
CCRK is a novel signalling hub exploitable in cancer immunotherapy
Keywords: مرگ برنامهریزی لیگاند 1; 9G8; serine and arginine rich splicing factor 7; AKT; AKT serine/threonine kinase; AR; androgen receptor; ARE; androgen response element; ARG1; arginase 1; ATM; ataxia telangiectasia mutated; ATR; ataxia telangiectasia and rad3-related protein; BMDC; mous
The effect of IκK-16 on lipopolysaccharide-induced impaired monocytes
Keywords: مرگ برنامهریزی لیگاند 1; DAMPs; danger-associated molecular patterns; ELISA; enzyme-linked immunosorbent assay; G-CSF; granulocyte-colony stimulating factor; GM-CSF; granulocyte-macrophage colony-stimulating factor; IFN-γ; interferon-gamma; IL-10; interleukin-10; IκK; inhibitor
Cooperativity of HOXA5 and STAT3 Is Critical for HDAC8 Inhibition-Mediated Transcriptional Activation of PD-L1 in Human Melanoma Cells
Keywords: مرگ برنامهریزی لیگاند 1; HDAC; histone deacetylase; HOXA5; homeobox A5; PD-1; programmed death 1; PD-L1; programmed death-ligand 1; shRNA; short hairpin RNA; STAT3; signal transducer and activator of transcription 3;
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome
Keywords: مرگ برنامهریزی لیگاند 1; IFN; interferon; ISGs; IFNstimulated genes; HCV; hepatitis C virus; IL-10; interleukin-10; PDL-1; programmed death-ligand 1; LCMV; lymphocytic choriomeningitis virus; IFNAR; IFNA receptor; IRFs; IFN regulatory factors; pDCs; plasmacytoid dendritic cells;
Case reportEGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50%
Keywords: مرگ برنامهریزی لیگاند 1; Adenocarcinoma; NSCLC; Epidermal growth factor; Anaplastic lymphoma kinase; Programmed death-ligand 1;
CD40 agonist converting CTL exhaustion via the activation of the mTORC1 pathway enhances PD-1 antagonist action in rescuing exhausted CTLs in chronic infection
Keywords: مرگ برنامهریزی لیگاند 1; CD40 agonist; PD-1 antagonist; Chronic infection; CTL exhaustion; mTORC1 pathway; CTL; cytotoxic T lymphocytes; DT; diphtheria toxin; DC; dendritic cell; LCMV; lymphocytic choriomeningitis virus; OVA; ovalbumin; PD-1; programmed cell death protein 1; PD-L
Original researchProgrammed death-ligand 1 expression and T790M status in EGFR-mutant non-small cell lung cancer
Keywords: مرگ برنامهریزی لیگاند 1; Programmed death-ligand 1; T790M; Epidermal growth factor receptor mutation; Non-small cell lung cancer; Rebiopsy;
Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis
Keywords: مرگ برنامهریزی لیگاند 1; CI; confidence interval; HR; hazard ratio; OR; odds ratio; PD-1; programmed death-1; PD-L1; programmed death-ligand 1; p-stage; pathological stage; SI; smoking index; B7-H3; Immune checkpoint; Immunotherapy; Lung cancer; Smoking; Prognostic interaction;
Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma
Keywords: مرگ برنامهریزی لیگاند 1; SPP1; secreted phosphoprotein 1; PD-L1; programmed death-ligand 1; TAM; tumor-associated macrophage; MMPs; matrix metalloproteinases; CTL; cytotoxic T lymphocyte; SPP1; Macrophage polarization; Lung adenocarcinoma; PD-L1; TAMs;
Original ResearchComparative analysis of PD-L1 expression between primary and metastatic pulmonary adenocarcinomas
Keywords: مرگ برنامهریزی لیگاند 1; Programmed death-ligand 1; Pulmonary adenocarcinoma; Immune checkpoint; PD-1 blockade; Cancer immunotherapy;
High Frequency of Programmed Death-ligand 1Â Expression in Emphysematous Bullae-associated Lung Adenocarcinomas
Keywords: مرگ برنامهریزی لیگاند 1; Emphysematous bullae; Lung adenocarcinoma; Programmed death-ligand 1; Surgery;
The good and the bad faces of STAT1 in solid tumours
Keywords: مرگ برنامهریزی لیگاند 1; BAD; Bcl2-associated agonist of cell death; Bcl; B-cell lymphoma; CD; cluster of differentiation; CDK; cyclin-dependent kinase; CTL; cytotoxic T lymphocyte; CUG; cancer upregulated gene; CXCL; C-X-C motive ligand; DC; dendritic cells; DAMP; danger-associa
Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: AÂ RENAPE study
Keywords: مرگ برنامهریزی لیگاند 1; Peritoneal mesothelioma; Epithelioid subtype; PD-L1; Immunohistochemistry; Survival; EPMM; epithelioid peritoneal malignant mesothelioma; PD-L1; programmed death-ligand 1; PD-1; programmed death 1; CRSÂ +Â HIPEC; cytoreductive surgery combined with hypert
Hematologic neoplasms: Dendritic cells vaccines in motion
Keywords: مرگ برنامهریزی لیگاند 1; DCs; dendritic cells; TAA; tumor-associated antigens; APC; antigen presenting cells; mDCs; myeloid dendritic cells; pDCs; plasmacytoid dendritic cells; HLA; human leukocyte antigen; Ag Antigens; abs antibodies; PBMCs; peripheral blood mononuclear cells; G
Recommendations on surveillance and management of biallelic mismatch repair deficiency (BMMRD) syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer
Keywords: مرگ برنامهریزی لیگاند 1; BMMRD; biallelic mismatch repair deficiency; CMMRD; constitutional mismatch repair deficiency; CRC; colorectal cancer; GRADE; Grades of Recommendation, Assessment, Development and Evaluation; LS; Lynch syndrome; MLH; Mut L homolog 1; MSH2; Mut S homolog 2
Polymyositis induced by PD-1 blockade in a patient in hepatitis B remission
Keywords: مرگ برنامهریزی لیگاند 1; Immune-checkpoint inhibitors; Polymyositis; Immunological memory; Molecular mimicry; HBV; hepatitis B virus; ICI; immune checkpoint inhibitor; ICIM; immune checkpoint inhibitor-induced myopathy; IIM; idiopathic inflammatory myopathy; IRAE; immune-related
Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases
Keywords: مرگ برنامهریزی لیگاند 1; Lung adenocarcinoma; Programmed death-ligand 1; PD-L1; Tumor-infiltrating lymphocyte; Lymph node metastasis; Adjuvant therapy;
Original ArticleImmunology/InfectionEarly Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma Progression
Keywords: مرگ برنامهریزی لیگاند 1; CFSE; carboxyfluorescein succinimidyl ester; DCs; dendritic cells; LNs; lymph nodes; PD-L1; programmed death-ligand 1; rDCs; resident DCs; TIDCs; tumor-infiltrating dendritic cells; VEGFR-2; vascular endothelial growth factor receptor 2;
Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer
Keywords: مرگ برنامهریزی لیگاند 1; Pancreatic cancer; T cells; Exhaustion; Immunotherapy; ACT; adoptive cell transfer; AP-1; activator protein-1; APC; antigen-presenting cells; CAR; chimeric antigen receptor; CTL; cytotoxic T cells; CTLA-4; cytotoxic T lymphocyte antigen 4; FDA; US Food an
Increased, but Functionally Impaired, CD14+ HLA-DR-/low Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T Cells
Keywords: مرگ برنامهریزی لیگاند 1; iTreg; induced regulatory T cell; MDSC; myeloid-derived suppressor cell; Mo-MDSC; monocytic myeloid-derived suppressor cell; PBMC; peripheral blood mononuclear cell; PD-1; programmed cell death protein 1; PD-L1; programmed death-ligand 1; ROS; reactive ox
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma
Keywords: مرگ برنامهریزی لیگاند 1; Lung cancer; NSCLC; Programmed death-ligand 1; Immunohistochemistry; Immunotherapy; Biomarker;
Programmed death-1 (PD-1)/PD-1 ligand pathway–mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders
Keywords: مرگ برنامهریزی لیگاند 1; Human T-lymphotropic virus-1; Cytotoxic T lymphocyte Programmed death-1; Programmed death-ligand 1; T-cell costimulation
Contributions of PD-1/PD-L1 pathway to interactions of myeloid DCs with T cells in atherosclerosis
Keywords: مرگ برنامهریزی لیگاند 1; Programmed death-1; Programmed death-ligand 1; Atherosclerosis; Myloid dendritic cell; Interferon